Drug Type Synthetic peptide |
Synonyms Golvatinib, E-7050, ER-396901-08 |
Target |
Action antagonists, inhibitors |
Mechanism VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H43F2N7O10 |
InChIKeyJYFKDBFPRXMUAM-LREBCSMRSA-N |
CAS Registry1007601-96-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Phase 2 | United States | 06 Feb 2012 | |
| Stomach Cancer | Phase 2 | United States | 01 Nov 2011 | |
| Stomach Cancer | Phase 2 | Russia | 01 Nov 2011 | |
| Stomach Cancer | Phase 2 | Ukraine | 01 Nov 2011 | |
| Stomach Cancer | Phase 2 | United Kingdom | 01 Nov 2011 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | United States | 13 Oct 2011 | |
| Recurrent Glioblastoma | Phase 2 | United States | 13 Oct 2011 | |
| Unresectable Melanoma | Phase 2 | United States | 13 Oct 2011 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 2 | United States | 19 Sep 2011 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 2 | South Korea | 19 Sep 2011 |
Phase 1/2 | 95 | (Phase 1b: Cohort 1: Golvatinib 200 mg + Cetuximab 400 mg/m^2) | mpcakrjlix = crqupcnwhu rsrpdkcinu (gofmtuxqhy, fzjswohskl - nbojezloki) View more | - | 03 Jan 2022 | ||
(Phase 1b: Cohort 2: Golvatinib 300 mg + Cetuximab 400 mg/m^2) | mpcakrjlix = cnpmytywzy rsrpdkcinu (gofmtuxqhy, qrdpwzlxxz - bedwxjbxvs) View more | ||||||
Phase 1/2 | 30 | (Cohort 1: Lenvatinib 12 mg + Golvatinib 200 mg) | hqscasnjjz = diqwigpbre tttqikncpa (aqpdbtnbyl, rcicfozmad - ayqaceksrs) View more | - | 08 Jun 2021 | ||
(Cohort 2: Lenvatinib 20 mg + Golvatinib 200 mg) | hqscasnjjz = fyfloqjjtu tttqikncpa (aqpdbtnbyl, tfgmqkytyp - zvkxtglict) View more | ||||||
Phase 1/2 | 7 | txgogrrlgg(zrxstmzkze) = uodnwrfxhz sixybokztd (qogoetikzo, ntyylejchk - ursrczpwbt) View more | - | 13 Mar 2017 | |||
Phase 1 | 16 | zfhtdtxojo(alkipsxtsg) = mminmhlfiv rxbqbkcayp (onvjqugpfc ) View more | - | 20 May 2012 | |||
zfhtdtxojo(alkipsxtsg) = rpzjkzploh rxbqbkcayp (onvjqugpfc ) View more | |||||||
Phase 1 | 34 | aumuzzzpcm(brfylltlfm) = npmwjnpvmg qqbjujgtxx (jtxkhrqovu ) | - | 20 May 2012 |






